These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 1498003

  • 1. Amelioration of hypertension and insulin resistance by 1,25-dihydroxycholecalciferol in hemodialysis patients.
    Mak RH.
    Pediatr Nephrol; 1992 Jul; 6(4):345-8. PubMed ID: 1498003
    [Abstract] [Full Text] [Related]

  • 2. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients.
    Mak RH.
    Kidney Int; 1992 Apr; 41(4):1049-54. PubMed ID: 1513086
    [Abstract] [Full Text] [Related]

  • 3. Long-term 1,25-dihydroxycholecalciferol treatment in renal failure.
    Hortling L, Fyhrquist F, Bonsdorff MV, Holmberg P, Edgren J, Kock B, Tella M, Eklund B, Holmström T.
    Acta Med Scand; 1983 Apr; 214(1):55-60. PubMed ID: 6353876
    [Abstract] [Full Text] [Related]

  • 4. Insulin secretion in uremia: effect of parathyroid hormone and vitamin D metabolites.
    Mak RH.
    Kidney Int Suppl; 1989 Nov; 27():S227-30. PubMed ID: 2699996
    [Abstract] [Full Text] [Related]

  • 5. Intravenous calcitriol normalizes insulin sensitivity in uremic patients.
    Kautzky-Willer A, Pacini G, Barnas U, Ludvik B, Streli C, Graf H, Prager R.
    Kidney Int; 1995 Jan; 47(1):200-6. PubMed ID: 7731147
    [Abstract] [Full Text] [Related]

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 7. No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects.
    Fliser D, Stefanski A, Franek E, Fode P, Gudarzi A, Ritz E.
    Eur J Clin Invest; 1997 Jul; 27(7):629-33. PubMed ID: 9263752
    [Abstract] [Full Text] [Related]

  • 8. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
    Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.
    Nephron Clin Pract; 2008 Jul; 110(1):c58-65. PubMed ID: 18724068
    [Abstract] [Full Text] [Related]

  • 9. [Large artery wall properties in dialyse and renal transplant patients with normal blood pressure].
    Posadzy-Małaczyńska A, Kosch M, Hausberg M, Rahn KH, Małaczyński P, Głuszek J, Tykarski A.
    Wiad Lek; 2004 Jul; 57(11-12):611-6. PubMed ID: 15865237
    [Abstract] [Full Text] [Related]

  • 10. 1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia.
    Mak RH.
    Kidney Int; 1998 May; 53(5):1353-7. PubMed ID: 9573552
    [Abstract] [Full Text] [Related]

  • 11. Effects of 1,25-dihydroxycholecalciferol on intestinal calcium transport in cortisone-treated rats.
    Favus MJ, Walling MW, Kimberg DV.
    J Clin Invest; 1973 Jul; 52(7):1680-5. PubMed ID: 4718960
    [Abstract] [Full Text] [Related]

  • 12. Interaction between dietary 1,25-dihydroxycholecalciferol and calcium and effects of management on the occurrence of tibial dyschondroplasia, leg abnormalities and performance in broiler chickens.
    Rennie JS, McCormack HA, Farquharson C, Berry JL, Mawer EB, Whitehead CC.
    Br Poult Sci; 1995 Jul; 36(3):465-77. PubMed ID: 7583377
    [Abstract] [Full Text] [Related]

  • 13. Control of parathyroid function in patients with a short history of hemodialysis.
    Nishi H, Sato T, Kurihara T, Kurosawa T, Fukagawa M.
    Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
    [Abstract] [Full Text] [Related]

  • 14. Successful treatment of renovascular hypertension has no effect on insulin sensitivity.
    Voiculescu A, Hollenbeck M, Kutkuhn B, Grabensee B, Plum J.
    Eur J Clin Invest; 2003 Oct; 33(10):848-54. PubMed ID: 14511355
    [Abstract] [Full Text] [Related]

  • 15. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A, Bahceci M, Yilmaz ME, Turgut C, Kara IH.
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [Abstract] [Full Text] [Related]

  • 16. The role of abdominal adiposity and insulin resistance in dyslipidemia of chronic renal failure.
    Lee P, O'Neal D, Murphy B, Best J.
    Am J Kidney Dis; 1997 Jan; 29(1):54-65. PubMed ID: 9002530
    [Abstract] [Full Text] [Related]

  • 17. The vitamin D/parathyroid hormone axis in the pathogenesis of hypertension and insulin resistance in uremia.
    Mak RH, Wong JH.
    Miner Electrolyte Metab; 1992 Jan; 18(2-5):156-9. PubMed ID: 1465050
    [Abstract] [Full Text] [Related]

  • 18. Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD.
    Quarles LD, Yohay DA, Carroll BA, Spritzer CE, Minda SA, Bartholomay D, Lobaugh BA.
    Kidney Int; 1994 Jun; 45(6):1710-21. PubMed ID: 7933819
    [Abstract] [Full Text] [Related]

  • 19. Hypoparathyroidism.
    Breslau NA, Pak CY.
    Metabolism; 1979 Dec; 28(12):1261-76. PubMed ID: 390300
    [Abstract] [Full Text] [Related]

  • 20. Effects of 1alpha,25-dihydroxycholecalciferol and cortisol on the growth and differentiation of primary cultures of mouse mammary epithelial cells in collagen gel.
    Kanazawa T, Enami J, Kohmoto K.
    Cell Biol Int; 1999 Dec; 23(7):481-7. PubMed ID: 10728785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.